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Nucleotide Excision Repair (NER) isa pathway that removes lesions dis-
torting the DNA helix. The molecular
basis of the rare diseases Xeroderma pig-
mentosum (XP) and Cockayne Syndrome
(CS) are explained based on the defects
happening in 2 NER branches: Global-
Genome Repair and Transcription-Cou-
pled Repair, respectively. Nevertheless,
both afflictions sporadically occur
together, giving rise to XP/CS; however,
the molecular basis of XP/CS is not
understood very well. Many efforts have
been made to clarify why mutations in
only 4 NER genes, namely XPB, XPD,
XPF and XPG, are the basis of this dis-
ease. Effort has also been made to unravel
why mutations within these genes lead to
XP, XP/CS, or other pathologies. We
have recently contributed to the disclo-
sure of this puzzle by characterizing
Rad3/XPD mutations in Saccharomyces
cerevisiae and human cells. Based on our,
and others’, observations, we propose a
model compatible with all XP/CS cases
and the current bibliography.
Introduction
Xeroderma pigmentosum (XP) and
Cockayne syndrome (CS) are rare autoso-
mal inherited recessive disorders. XP is
characterized by cutaneous symptoms
because of exposure to sunlight, pigmen-
tation abnormalities, skin atrophy and a
high incidence of skin cancer (up to
10000-fold increase)1 and mucous mem-
brane cancer due to the defect in repair of
UV- or carcinogen-induced lesions.
About 20% of XP patients also display
neurological defects that could be
explained by neuronal degeneration
caused by defects in repair of oxidative
damage in the brain region. CS patients
display severe growth failure and neuro-
logical dysfunction due to demyelization,
as well as cachectic dwarfism, ocular
abnormalities, sensorineural deafness,
dental cavities, microcephaly, skeletal
abnormalities, intracranial calcification
and mental retardation (For a review see
refs.2, 3). In addition, there is a small
group of patients that exhibits XP/CS, a
combination of clinical symptoms of the
2 diseases.
At the cellular level, the XP and CS
conditions are both associated with
defects in Nucleotide Excision Repair
(NER). This highly orchestrated repair
mechanism detects helical distortions as
well as DNA thermodynamic destabiliza-
tions, signaling them as DNA lesions by
specialized proteins. This drives the bind-
ing of a protein complex named TFIIH,
which allows DNA unwinding, damaged
DNA strand recognition and recruitment
of specific nucleases that excise the dam-
aged DNA segment. Finally, DNA syn-
thesis fills the remaining single-stranded
DNA (ssDNA) gap. The XP molecular
basis is explained by defects in Global-
Genome Repair (GGR), in which lesions
are recognized all over the genome,
whereas the molecular basis of CS has
been classically explained by defects in
Transcription-Coupled Repair (TCR), a
NER subpathway in which the lesions
are encountered and signaled by the elon-
gating RNA polymerase II, and thus
more efficiently repaired in the tran-
scribed DNA strand.4
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ADDENDUM
The XP/CS paradox
A dysfunction exclusively associated
with NER during transcription, as that
linked to CS without XP manifestation, is
due to defects in the proteins CSA and
CSB that recognize the lesion at the tran-
scribed site and promote the recruitment
of the rest of the NER proteins. However,
there are mutations in the XPB, XPD,
XPF or XPG genes associated with either
XP-only or XP/CS syndromes. On top of
that, all mutations described for XPA only
confer XP syndrome. Since all the men-
tioned factors are important for the same
repair pathway, it becomes difficult to dis-
sect the molecular basis of XP/CS.
The characterization of a particular
subset of mutants of the yeast Saccharo-
myces cerevisiae has proven useful to start
understanding this puzzle.5 We have
further worked with mutations of the
Rad3/XPD helicase, central to the
above-mentioned TFIIH complex. This
helicase hydrolyses ATP to open the
DNA around the NER lesion so that it
can be removed. However, TFIIH also
has a fundamental role in the initiation
of transcription, since it allows promoter
opening via another helicase, Rad25/
XPB, and promotes RNA polymerase
escape to start elongation.6 The latter
function is achieved by the kinase activ-
ity of the CDK Activating Kinase
(CAK), a subcomplex of TFIIH. In
transcription, the Rad3/XPD role is
strictly structural, serving to bridge the
CAK with the rest of the complex.6,7
Fundamentally, rad3 mutants can be
ascribed either to those being highly
UV-sensitive, because of a NER defect,
and those bearing transcription initia-
tion problems, due to a defect in the
TFIIH assembly. We have used a bat-
tery of rad3 mutants whose main feature
was none of the above: irrespective of
their UV sensitivity and without any
apparent transcription defect, they
require for survival an a priori unrelated
DNA repair system, homologous recom-
bination (HR), to be intact. These rad3
mutants are named rem (for increased
recombination and mutation levels)8
and they all share the feature of har-
bouring their mutation in the ATP-
binding groove of the protein.9 This
fact was highly intriguing since all
reported XP/CS patients linked to an
XPD deficiency bear their mutations
within this same domain.
To understand the molecular defect
occurring in these mutants we envision
the ATPase activity of Rad3 during NER
as 2 sides of a coin: it becomes critical for
its helicase ability, but it conditions affin-
ity of the protein for ssDNA9 (Fig. 1).
On this premise, when the mutations in
the ATP-binding groove affect it so dra-
matically that no helicase activity at all
can be exerted, the DNA will remain
unwound and the TFIIH complex har-
bouring the mutant Rad3 will float away
leaving the lesion unrepaired.10 This
should lead to high UV sensitivity, that is,
mimicking an XP phenotype. On the con-
trary, if the mutation has a weak effect
that allows DNA melting, once bound, it
will promote a stronger binding of the
TFIIH complex to the opened DNA.5
This scenario will not only allow damage
excision (at least to a certain extent) but it
will affect the on-time recruitment of the
DNA synthesis machinery,11 leaving a
long-lasting ssDNA repair intermediate.
In non-cycling cells this may lead to
extensive resection of the processed DNA
strand, subsequent accumulation of
ssDNA and therefore genetic instability.12
In dividing cells, the ssDNA gap would be
converted into a double strand break
(DSB) when an incoming replication fork
hits the unfinished NER intermediate.5
This replication-born DSB requires repair
via HR. In addition, the longer persistence
of the TFIIH complex at the damaged
sites would prevent it from performing
new rounds of transcription initiation at
promoters, explaining why transcription
defects may arise after DNA damage.
Altogether, this cascade of events would
explain an XP/CS-like phenotype. In this
view, the transcription-related defects
would be TCR-independent, and there-
fore serve to explain the paradox presented
above. Our model is in agreement with
recent findings in various different mod-
els: recreation of mutations in the ATP-
binding groove of Sulfolobus acidocaldarius
XPD leads both to a loss of helicase activ-
ity and a gain of affinity for ssDNA;13 in
mice, an XP-D/CS-mimicking mutation
has been shown to provoke an unfinished
NER intermediate that leads to extensive
Figure 1. Proposed molecular defects in Rad3 ATP-binding groove mutants that may help under-
stand XP/CS. The severity of the ATPase defect of rad3/XPD mutants would correlate with both its
incapacity of DNA bubble opening and its ssDNA afﬁnity. Mutants more affected were presumed to
be the most UV-sensitive, rad3–2 and rad3–107, whereas rad3–101 and rad3–102 would display an
intermediate defect, thus allowing eventual opening of the damaged DNA and a major perma-
nence of the TFIIH complex at the DNA.
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accumulation of ssDNA and subsequent
transcription inhibition;14 in XP-D/CS
patients cells, the inhibition of transcrip-
tion after UV is not general but only
affects those genes whose promoters were
specifically abandoned by TFIIH in
response to the damage. Moreover, this
correlates with heterochromatinization of
the same promoters, tentatively because
the retour of the complex is delayed.15 A
gradient of phenotypes is expected consid-
ering that different mutations in the ATP-
binding groove of Rad3/XPD will confer
different degrees of helicase inactivation
and different levels of gain of affinity for
ssDNA, which would explain the various
outcomes in the distinct patients.
CAK dissociation from TFIIH as
a marker of XP/CS
One of the approaches we have under-
taken in order to obtain some idea of the
molecular basis of XP/CS has been Fluo-
rescence Recovery After Photo-bleaching
(FRAP) in S. cerevisiae Rad3 ATP-bind-
ing groove mutants.9 After UV irradia-
tion, the percentage of the fluorescence in
the bleached area that cannot be recov-
ered indicates the fraction of TFIIH that
is engaged somewhere else performing
repair. The time in which the given
recovery is achieved is proportional to the
molecular weight of the complex being
analyzed.16 When the latter quantifica-
tion was done (by plotting the data rela-
tive to a normalized maximum value), we
perceived differences in the slopes among
the various strains, indicative of faster
TFIIH mobility in the mutants down to
reaching the WT situation, in which
mobility was the slowest9 (Fig. 2). The
TFIIH mobility curve, expressed as the
mean of the different states of association
of a protein with its different partners,
had indeed been characterized for a given
TFIIH protein.17 In these assays, the
steepest slope would mean a higher frac-
tion of assembled TFIIH complexes with
lower molecular weight (rad3–2 mutant
(Rad3-G461R)). Still lower TFIIH
molecular weight within the total TFIIH
population would show up in the other
mutants (with intermediately steep
slopes), while the amount of TFIIH low
molecular weight would be minimal in
the WT strain (Fig. 2). Interestingly, the
module whose dissociation would dimin-
ish low molecular weight TFIIH could
be the CAK subcomplex. The CAK sub-
complex is released from the core TFIIH
during NER, which is known to stimu-
late incision and repair of damaged
DNA, while its re-association does not
occur until resumption of transcription.18
A relevant consequence of having an
excess of free CAK is an alteration in cell
cycle progression, since many key proteins
controlling cell cycle stages are targets of
the CAK kinase Cdk7.19 Thus, in Dro-
sophila embryos, excess of XPD titrates
CAK activity resulting in defects at mito-
sis, while down regulation of XPD leads
to an excess of free CAK and a burst in
proliferation.20 In agreement, the yeast
mutants rad3–102 (Rad3-H661Y) and
rad3–2 show faster entry into the S-
phase.5, 21 Altogether, these observations
would suggest that an excess of free CAK
is a feature of XP-D/CS cells. Indeed, the
idea of an excess of free CAK has already
been proposed as a molecular hallmark of
all XP/CS pathologies.22,23 The proposals
were raised because an excess of free CAK
had been reported in different XP/CS
cells, as is the case of XP-G/CS cells,24
and in XP-D/CS cells, which furthermore
show aberrant chromosome segregation
due to premature commitment to
mitosis.25
An alternative molecular defect for
the XP/CS condition
Despite all previous considerations,
some observations were noted in the past
that do not fit the proposal that excess free
CAK is the molecular hallmark of XP/
CS.22 First, an XP-B/CS-causing muta-
tion (XPCS1BA patient) was not seen to
induce a relevant increase in free CAK24
and, second, mutations in the C-terminus
of XPD (XPD-R683W) weakening the
association of the CAK to TFIIH were at
the base of an XP, but not of an XP/CS,
condition.26 One simple way of resolving
these inconsistencies would be that the
excess of free CAK might just be one pos-
sible outcome in certain XP/CS condi-
tions, though not the molecular, causative
hallmark at the base of this pathology.
In order to solve these apparent con-
flicts, and sustain our proposal on the
available molecular characterizations,9,13,14
we propose that the molecular feature
common to all XP/CS conditions is the
persistence of bound TFIIH at an open
bubble and the inability to recruit the
DNA synthesis factors, which in turn
extends the permanence of an unfinished
NER intermediate (Fig. 3). This would
impair accurate completion of damage
repair and sequester TFIIH away from
transcription sites impairing transcription
resumption, which could explain the XP
and CS clinical manifestations.
Our model thus provides a uniform
explanation compatible with the role
during NER not only of XPD (see
above), but also of XPB, XPF and XPG.
Figure 2. TFIIH dynamics in Rad3 ATP-binding groove mutants. Representation of FRAP curves nor-
malized to a global maximum of Tfb4-yGFP strains after 80 J/m2 UV-C irradiation. Recovery curves
of the normalized ﬂuorescence in wild-type (WT) and rad3 mutants affected in the ATP-binding
groove of Rad3 (rad3–102 [Rad3-H661Y], rad3–101 [Rad3-A237T], rad3–107 [Rad3-E236G] and rad3–
2 [Rad3-G461R]) are displayed (adapted from data in ref.9). The different steepness of the linear
part of the curves shows the average molecular weight of the TFIIH complex under measurement.
www.tandfonline.com e1079362-3Rare Diseases
XPB-associated ATPase activity needs to
be exerted for NER.27 In analogy with
XPD, any loss of ATPase activity in con-
text of a functional TFIIH may cause a
gain of affinity for DNA.28 The recently
uncovered patient whose XP/CS condi-
tion was associated with an XPF defi-
ciency29 can also be described on the
basis of an opened NER bubble without
further incision. As for XP-G/CS-caus-
ing mutations, it has been shown that
they prevent the XPG interaction with
TFIIH and may even cause CAK and
XPD dissociation.24 TFIIH association
with the lesion may therefore occur, but
the inability to recruit XPG halts
incision by both XPF-ERCC1 and XPG
at the 50 side or at the 30 side of the
lesion, respectively,22,30 and may even
cause late XPD and CAK dissociation,
leaving an aberrant repair bubble with-
out further processing.24 There is evi-
dence supporting this hypothesis. First,
XPB mutations leading to XP/CS have
been shown to fully allow TFIIH
recruitment and subsequent assembly of
the incision nucleases,11 which is accom-
panied by bubble opening and XPG
incision. Since this XPB mutation
impairs XPF incision,31 the NER inter-
mediate is long lasting32 and DNA syn-
thesis does not take place.11 Second,
XPG mutations leading to XP/CS are as
well able to promote TFIIH assembly
and bubble establishment, but recruit-
ment of DNA synthesis factors is pre-
vented.11 Altogether, we propose the
long-lasting NER intermediate as the
general molecular defect underlying all
XP/CS deficiencies, irrespective of
whether it is XPD, XPB, XPF or XPG
being mutated (Fig. 3). As a conse-
quence, and only in some circumstances,
this may lead to an excess of free CAK.
Therapeutic possibilities of the model
Some therapeutic considerations
could be derived from our proposal. If
Figure 3. A possible uniﬁed model to explain the XP/CS molecular defect. In a normal situation, TFIIH is recruited to the damaged site, releasing the CAK
subcomplex and allowing DNA unwinding and excision of the DNA containing the lesion by the XPF and XPG endonucleases. After DNA repair comple-
tion, TFIIH is relocated to the promoter sites, thus allowing transcription resumption. In XP/CS cells, TFIIH is also recruited to the damaged site and per-
forms bubble opening. Incision by XPF or XPG nucleases could be prevented. In all cases, TFIIH could be retained in the DNA as a long-lasting NER
intermediate. As a consequence, DNA synthesis would be impaired and DNA break formation may occur whenever incision has happened. TFIIH reten-
tion would provoke a delay in transcription resumption. In this scenario, an excess of free CAK is a possible outcome of some XP/CS mutations. Proteins
whose deﬁciencies can cause an XP/CS condition are highlighted in red: XPB, XPD, XPF and XPG.
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the mutations at the base of XP/CS are
causing the molecular defect we have
described here, namely a long-lasting
NER intermediate, this could be
exploited for XP/CS-associated cancer
treatment. As previously explained, the
impact of these mutations would be dif-
ferent in non-dividing versus cycling
cells. The latter would present an acute
dependency on HR functions in order
to tolerate the unfinished NER. In the
absence of HR, DSBs would accumu-
late in their genomes, eventually leading
to cell death. Given that cancer cells
cycle more frequently than most body
cells, inhibition of HR could be
explored as a therapeutic approach to
XP/CS-associated cancers. Moreover,
not only the spontaneous damage that
is a substrate of NER would generate
DSBs in an XP/CS-like context, but
also their production could be exacer-
bated if cells are directly challenged
with UV light-mimetic drugs.9 Thus, if
the local delivery of such drugs in com-
bination with HR inhibitors is feasible,
this could be investigated as a way to
hyper-sensitize XP/CS cancer cells.
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